Patent details

Basic Information

Publication number:

EP2170403

PCT Application Number:

PCT/IL/2008/000874

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP087636312

PCT Publication Number:

WO/2009/001359

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Compositions and methods for inhibiting expression of pro-apoptotic genes

French Title of Invention:

Compositions et procédés d'inhibition de l'expression de gènes pro-apoptotiques

German Title of Invention:

Zusammensetzungen und Verfahren zur Unterdrückung der Expression von pro-apoptotischen Genen

SPC Number:

Dates

Filing date:

26/06/2008

Grant date:

16/04/2014

EP Publication Date:

16/04/2014

PCT Publication Date:

31/12/2008

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

07/04/2010

EP B1 Publication Date:

16/04/2014

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

26/06/2014

Expiration date:

26/06/2028

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

26/06/2008

 

 

Name:

Quark Pharmaceuticals Inc.

Address:

6501 Dumbarton Circle, Fremont, California 94555, United States (US)

Inventor

1

Name:

ERLICH Shai, Dr

Address:

United States (US)

2

Name:

KALINSKI Hagar

Address:

Israel (IL)

3

Name:

FEINSTEIN Elena

Address:

Israel (IL)

4

Name:

METT Igor

Address:

Israel (IL)

Priority

1

Priority Number:

937318 P

Priority Date:

27/06/2007

Priority Country:

United States (US)

2

Priority Number:

964325 P

Priority Date:

10/08/2007

Priority Country:

United States (US)

Classification

Main IPC Class:

C12N 15/113;

Filing date	Document type	Number of pages